• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Introduction to N-(Pyridin-2-ylmethyl)propan-2-amine and Its Significance in Modern Chemical Research

N-(Pyridin-2-ylmethyl)propan-2-amine (CAS No. 58669-30-0) is a compound of considerable interest in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, characterized by its pyridine moiety linked to a propylamine group, has garnered attention due to its versatile structural features and potential applications in drug discovery and material science.

The structural motif of N-(Pyridin-2-ylmethyl)propan-2-amine combines the electron-deficient nitrogen of the pyridine ring with the nucleophilic amine functionality, making it a valuable intermediate in the synthesis of more complex molecules. The pyridine ring, in particular, is a common pharmacophore in many biologically active compounds, contributing to interactions with various biological targets. The propylamine group adds further reactivity, enabling a range of functionalization strategies that can be exploited in medicinal chemistry.

In recent years, there has been growing interest in the development of small-molecule modulators that can interact with biological pathways involved in neurological disorders, cancer, and inflammation. N-(Pyridin-2-ylmethyl)propan-2-amine has emerged as a promising scaffold for such applications due to its ability to modulate enzyme activity and receptor binding. For instance, derivatives of this compound have been investigated for their potential as kinase inhibitors, where the pyridine moiety can engage with the ATP-binding site of target enzymes.

One of the most compelling aspects of N-(Pyridin-2-ylmethyl)propan-2-amine is its synthetic accessibility. The compound can be readily prepared through a variety of methods, including alkylation reactions between 2-pyridinemethanol and propylamine derivatives. This ease of synthesis makes it an attractive building block for large-scale drug development programs. Additionally, the presence of both the pyridine and amine functionalities allows for further derivatization through cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which can introduce aryl or heteroaryl groups into the molecule.

The pharmacological profile of N-(Pyridin-2-ylmethyl)propan-2-amine has been explored in several preclinical studies. Researchers have demonstrated that certain derivatives exhibit inhibitory activity against targets such as Janus kinases (JAKs) and tyrosine kinases (Tyrosine Kinase Inhibitors - TKIs). These kinases are implicated in various signaling pathways that regulate cell growth, differentiation, and survival, making them attractive therapeutic targets for conditions like rheumatoid arthritis and certain types of cancer.

In addition to its applications in drug discovery, N-(Pyridin-2-ylmethyl)propan-2-amine has shown promise in material science. Its ability to form coordination complexes with transition metals has led to investigations into its use as a ligand in catalytic systems. For example, palladium complexes derived from this compound have been studied for their potential as catalysts in cross-coupling reactions, which are fundamental transformations in organic synthesis.

The versatility of N-(Pyridin-2-ylmethyl)propan-2-amine is further highlighted by its role in the development of chiral auxiliaries and ligands. The introduction of stereocenters into this scaffold can lead to enantiomerically pure compounds that exhibit enhanced selectivity in biological assays. This is particularly important in pharmaceuticals, where enantiomeric purity can significantly influence a drug's efficacy and safety profile.

The latest research on N-(Pyridin-2-ylmethyl)propan-2-aminesuggests new avenues for therapeutic intervention. Studies have begun to explore its potential as an adjuvant in vaccine formulations, where its ability to modulate immune responses could enhance vaccine efficacy. Furthermore, its interaction with nucleic acids has opened up possibilities for applications in antisense therapy and gene editing technologies.

In conclusion, N-(Pyridin-2-yli...

• 1539-42-0(Bis(2-pyridylmethyl)amine)
• 51639-59-9(propyl[(pyridin-2-yl)methyl]amine)
• 51639-58-8(N-Ethyl-N-(2-pyridylmethyl)amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)